At Emerson Users Exchange 2009, FDA Senior Fellow Ali Afnan discussed QbD and responded to a question from the audience about pharmaceutical quality by design,and whether QbD submissions to the FDA so far had reduced product release testing. For more information, visit www.PharmaManufacturing.com.
Link to this comment:
All Comments (0)